| CB2 cannabinoid receptors as a therapeutic target—what does the future hold? A Dhopeshwarkar, K Mackie Molecular pharmacology 86 (4), 430-437, 2014 | 317 | 2014 |
| Synthesis of Photoswitchable Δ9-Tetrahydrocannabinol Derivatives Enables Optical Control of Cannabinoid Receptor 1 Signaling MV Westphal, MA Schafroth, RC Sarott, MA Imhof, CP Bold, P Leippe, ... Journal of the American Chemical Society 139 (50), 18206-18212, 2017 | 94 | 2017 |
| Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway A Dhopeshwarkar, K Mackie Journal of pharmacology and experimental therapeutics 358 (2), 342-351, 2016 | 91 | 2016 |
| Slowly signaling G protein–biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence X Lin, AS Dhopeshwarkar, M Huibregtse, K Mackie, AG Hohmann Molecular pharmacology 93 (2), 49-62, 2018 | 69 | 2018 |
| Cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal AL Li, X Lin, AS Dhopeshwarkar, AC Thomaz, LM Carey, Y Liu, SP Nikas, ... Molecular pharmacology 95 (2), 155-168, 2019 | 48 | 2019 |
| Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol N Murataeva, A Dhopeshwarkar, D Yin, J Mitjavila, H Bradshaw, ... Pharmacological research 110, 173-180, 2016 | 41 | 2016 |
| The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: inhibition by phthalate esters in vitro KM Bisset, AS Dhopeshwarkar, C Liao, RA Nicholson Neurochemistry international 59 (5), 706-713, 2011 | 37 | 2011 |
| Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing N Murataeva, S Miller, A Dhopeshwarkar, E Leishman, L Daily, X Taylor, ... Experimental eye research 182, 74-84, 2019 | 30 | 2019 |
| Two Janus cannabinoids that are both CB2 agonists and CB1 antagonists A Dhopeshwarkar, N Murataeva, A Makriyannis, A Straiker, K Mackie Journal of Pharmacology and Experimental Therapeutics 360 (2), 300-311, 2017 | 25 | 2017 |
| Cannabinoid-induced chemotaxis in bovine corneal epithelial cells N Murataeva, S Li, O Oehler, S Miller, A Dhopeshwarkar, SSJ Hu, ... Investigative Ophthalmology & Visual Science 56 (5), 3304-3313, 2015 | 24 | 2015 |
| The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB1 receptor in vitro AS Dhopeshwarkar, S Jain, C Liao, SK Ghose, KM Bisset, RA Nicholson European journal of pharmacology 654 (1), 26-32, 2011 | 22 | 2011 |
| Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea N Murataeva, L Daily, X Taylor, A Dhopeshwarkar, SSJ Hu, S Miller, ... Cornea 38 (7), 905-913, 2019 | 17 | 2019 |
| Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [3H] CP55940 … AS Dhopeshwarkar, RA Nicholson European Journal of Pharmacology 723, 431-441, 2014 | 5 | 2014 |
| A. Muciniphila; a Microbiome Mediator of Tetrahydrocannabinol Induced Weight Loss? M Rusling, T Lampeter, C Fung, C Love, A Dhopeshwarkar, K Mackie, ... The FASEB Journal 35, 2021 | | 2021 |
| Methods of using cannabinoid cb2 receptor agonist compositions to suppress and prevent opioid tolerance and withdrawal in a subject AG Hohmann, KP Mackie, LIN Xiaoyan, AS Dhopeshwarkar US Patent App. 16/256,787, 2019 | | 2019 |
| Design and synthesis of metabolically stable endocannabinoid analogs by reversing ester and amide group L Ji, S Nikas, Y Liu, A Korde, A Ciesielski, A Straiker, O Benchama, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
| Novel 2-arachidonoyl glycerol analogs with enhanced bio-activities and stabilities: Design, synthesis and in vitro biochemical evaluation Y Liu, SP Nikas, L Ji, A Korde, A Ciesielski, A Straiker, O Benchama, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |
Ken MackieProfessor Psychological and Brain Sciences, Indiana UniversityVerified email at indiana.edu
